Overview
- Legal name
- SAGENT PHARMACEUTICALS, INC
- Also known as
- SAGENT PHARMACEUTICALS, INC
- Registered location
- SCHAUMBURG, IL, USA
- Website
- Company website ↗
- Primary NAICS
- 325412 — Pharmaceutical Preparation Manufacturing
- Latest award activity
- Aug 11, 2026
Read company summary
SAGENT PHARMACEUTICALS, INC is associated with UEI PR1HCLM3FMW7 and CAGE 4RP13 in public federal records. AcornBids currently links 75 prime awards totaling $17.2M in obligations to this entity. Its largest recorded federal customer by obligations is Department of Health and Human Services. Its recorded federal awards include work classified as Pharmaceutical Preparation Manufacturing; Medicinal and Botanical Manufacturing. These categories describe the loaded award records, not a complete list of company capabilities. Its primary SAM.gov NAICS is 325412 (Pharmaceutical Preparation Manufacturing). Its public SAM.gov registration lists SCHAUMBURG, IL, USA.
At a glance
Not available
Why this customer concentration
Detailed agency totals are not available in this stored profile.
Largest positive coded-agency total ÷ all positive coded-agency totals × 100
Missing data is shown as unavailable.
Prime contract obligations across loaded award records. Obligations are not revenue or contract ceilings. Summary updated Sep 28, 2026. Refresh pending; these totals may be out of date.
Business information
Public SAM.gov registration details.
- Legal name
- SAGENT PHARMACEUTICALS, INC
- Doing business as
- SAGENT PHARMACEUTICALS, INC
- UEI
- PR1HCLM3FMW7
- CAGE
- 4RP13
- Registered address
- 1515 E WOODFIELD RD STE 1100, SCHAUMBURG, IL, 60173, USA
- Registration status
- Active
- Primary NAICS
- 325412 — Pharmaceutical Preparation Manufacturing
- SAM activation
- Feb 4, 2026
- Initial registration
- May 17, 2007
- Entity start
- May 5, 2006
- SAM updated
- Feb 4, 2026
- Registration expires
- Feb 2, 2027
- Fiscal year end
- Mar 31
- Place of incorporation
- WY, USA
Federal award analysis
Net transaction obligations by federal fiscal period.
Transaction history is not available in the loaded data. Annual funding is not estimated from current award totals.
Recent federal awards
Prime contract awards. Select an award to review its history and source evidence.
| Award / description | Awarding agency | Obligations | Start date | End date |
|---|---|---|---|---|
| 36C77026P0086CIPROFLOXAXIN IVPB | Department of Veterans Affairs | $275.6K | Aug 14, 2026 | Aug 28, 2030 |
| SPE2D326F172C4572043667!LEVOFLOXACIN 500 MG/100 ML-D5W 100ML | Department of Defense | $96 | Jun 5, 2026 | Jun 8, 2026 |
| SPE2D021D00034600081202!MANUFACTURE/DISTRIBUTOR BR-PHILADELPHIA | Department of Defense | $29.6M | Mar 4, 2021 | Not available |
| SPE2D326F135B4571894571!LEVOFLOXACIN 500 MG/100 ML-D5W 100ML | Department of Defense | $48 | May 20, 2026 | May 21, 2026 |
| SPE2D326F125F4571867271!METRONIDAZOLE 500 MG/100 ML 100ML | Department of Defense | $13 | May 15, 2026 | May 18, 2026 |
| SPE2D326F090J4571706829!LEVOFLOXACIN 500 MG/100 ML-D5W 100ML | Department of Defense | $24 | May 4, 2026 | May 5, 2026 |
| SPE2D326F059G4571632359!LEVOFLOXACIN 500 MG/100 ML-D5W 100ML | Department of Defense | $24 | Apr 27, 2026 | Apr 28, 2026 |
| SPE2D326F053N4571593537!LEVOFLOXACIN 500 MG/100 ML-D5W 100ML | Department of Defense | $96 | Apr 23, 2026 | Apr 24, 2026 |
| SPE2D326F050C4571576404!LEVOFLOXACIN 750 MG/150 ML-D5W 150ML | Department of Defense | $46 | Apr 22, 2026 | Apr 23, 2026 |
| SPE2D326F97464571389643!PROPOFOL 1,000 MG/100 ML VIAL 100ML | Department of Defense | $60 | Apr 7, 2026 | Apr 8, 2026 |
Upcoming positioning windows
Modeled recompete windows are estimates, not announced solicitations or guarantees.
Registration, certifications & contacts
| Registration evidence | Date |
|---|---|
| SAM updated | Feb 4, 2026 |
| Source loaded | Sep 26, 2026 |
| Initial registration | May 17, 2007 |
| Entity start | May 5, 2006 |
Registration classifications: Small Business. These are separate from the reported certificates above.
| Industry | Reported size status |
|---|---|
| 325411 — Medicinal and Botanical Manufacturing | Not reported |
| 325412 — Pharmaceutical Preparation Manufacturing | Not reported |
| 325413 — In-Vitro Diagnostic Substance Manufacturing | Not reported |
| 325414 — Biological Product (except Diagnostic) Manufacturing | Not reported |
| Contact | Role | Published contact methods | Evidence | Source date |
|---|---|---|---|---|
| RICK PETERMAN | Government business | Contact method not published | SAM registration | Not available |
| JOHN MORANO | Electronic business | Contact method not published | SAM registration | Not available |
Registered industries
- 325411 — Medicinal and Botanical Manufacturing
- 325412 — Pharmaceutical Preparation Manufacturing
- 325413 — In-Vitro Diagnostic Substance Manufacturing
- 325414 — Biological Product (except Diagnostic) Manufacturing
Registration classifications and published certificates do not by themselves establish eligibility for a particular solicitation. View SAM source
Related companies worth researching
Explore the customer, work and award-size evidence behind each match.
About SAGENT PHARMACEUTICALS, INC
What products and services appear in its federal awards?
Recorded award industries: 325412 — Pharmaceutical Preparation Manufacturing; 325411 — Medicinal and Botanical Manufacturing.
Recorded products and services: 6505 — Drugs and Biologicals.
Examples from recent award records:
These records describe federal award work, not every company capability. Review the award evidence.
Where is the company registered?
1515 E WOODFIELD RD STE 1100, SCHAUMBURG, Illinois 60173, United States
Registered location from SAM.gov; award performance locations may differ.
What is its primary registered industry?
325412 — Pharmaceutical Preparation Manufacturing.
Primary SAM.gov NAICS classification.
Which federal agencies are represented in its awards?
Department of Health and Human Services; Department of Veterans Affairs; Department of Defense.
Data coverage and methodology
Sources: SAM.gov registration, USAspending awards and transactions, and linked supporting records. Prime contract obligations, IDV ceilings and assistance amounts are kept separate. Missing records are not zero activity. Company claims are labeled separately. Recompete signals are rule-based scores out of 100. Positioning windows are AcornBids estimates.
No official subaward rows are loaded, so Acorn does not claim known teaming relationships.
Recently viewed companies
Keep your research moving
Save this company, track changes, and evaluate upcoming work against your targets.
Save to my research Find my fit